Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide to reduce perioperative respiratory adverse events in children with congenital heart disease and upper respiratory infection
ChiCTR2000034531Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of budesonide in Cardiovascular Malformation (CVM) and upper respiratory infection (URI) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Incidence of perioperative respiratory adverse events (PRAEs) and Incidence of cough within 24 hours after operation. Started Jul 2020; status: recruiting.
02
Drugs
budesonide
03
Conditions
Cardiovascular Malformation (CVM)upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2000034531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034531.